|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, March 23, 2020 ) Macular Edema Market
The global macular edema market was valued at USD 6.24 billion in 2017 and the market is estimated to grow at a CAGR of 10.43% in the forecasted period (2018-2025) to reach a market value of USD XX billion by 2025.
Market Growth:
Macular Edema is a condition in which fluid gathers in macular and leads to vision impairment and loss of vision in certain conditions.
Advancements in technologies in development of new drug delivery systems, introduction of new drug combinations, rise in macular edema patients are the major factors driving the growth of the macular edema market across the globe.
Increasing diabetic population which in turn could result in macular edema is also one of the factors driving the growth of the market. Stringent regulations across various regions, availability of alternative therapies, and high cost of the drugs/medication are the major factor restraining the growth of the market.
Market Segmentation
The macular edema market is segmented by clinical trial analysis, by molecular type, and by geography.
By geography, North America has the largest market share in 2017 accounting for more than half of the market value and this is followed by Europe. Emerging markets are witnessing a faster growth in the market with Asia-Pacific region growing at a faster growth rate.
Market Key Players
Novartis
Roche
Pfizer
Regeneron Pharmaceuticals
View full report: https://www.datamintelligence.com/research-report/macular-edema-market
Competitive Analysis
The global macular edema market is a consolidated market with top 4 companies accounting for the largest market share. Some of the recent industry developments include
FDA approves Roches “Lucentis” for treatment of diabetic retinopathy in people with diabetic macular edema
Eylea injection recommended for approval for the treatment of visual impairment due to diabetic macular edema in the European Union
Download free sample: https://www.datamintelligence.com/download-sample/macular-edema-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
